Injectable nanoparticles make blind retinas respond to light in preclinical study

AI Summary

Researchers developed injectable nanoparticles that act as artificial light receptors, enabling blind retinas to respond to light in preclinical models. These particles are injected into the eye and stimulate retinal nerve cells to transmit signals to the brain, suggesting potential for vision restoration therapies.

An international research team has developed microscopic particles that can make blind retinas respond to light. The particles act as tiny light receptors. Researchers inject them into the eye, where they settle close to nerve cells in the retina. When light hits the particles, it triggers electrical and chemical processes that can activate the nerve cells and prompt them to send signals toward the brain.